regenerative medicine Latest News

Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue.

WILMINGTON, NC: Eqalix, Inc, an emerging biotechnology company in the Regenerative Medicine space is scheduled to present at the 11th annual BIO Investor Forum in San Francisco at the Palace Hotel.

A trio of tissue engineering technologies developed by researchers and clinicians from Drexel, Penn and CHOP are moving one step closer to becoming viable options for vascular surgery, skin replacement and tissue regeneration.

WA Regenerative Medicine signed a milestone agreement today with University of Southern California, which aims at sharing research, and applying breakthrough medicine to help improve the lives of people in the Greater China Region.

Contact: Natalie Winehouse 503.446.5039 pr@goodpartnersinc.com oodpartnersinc.com GoodPartners Launches First Global Survey into Stem Cell Usage Portland, Oregon. Wednesday, May 15, 2013.

Explosive growth in the field of tissue engineering and regenerative medicine has led to innovative and promising applications and techniques, many of which are now being tested in human clinical...

Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue.

Penetrating soft tissue injuries that may be caused by bullet wounds or motor vehicle accidents, or exposure to explosive devices in military settings, can cause muscle loss resulting in functional disability and cosmetic deformity.

WILMINGTON, NC: Eqalix, Inc, an emerging biotechnology company in the Regenerative Medicine space is scheduled to present at the 11th annual BIO Investor Forum in San Francisco at the Palace Hotel.

This unique book offers a valuable benchmark for the current status of clinically relevant research and development in stem cells and regenerative medicine.

The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has extended its clinical monitoring services to advanced therapy trials – an important step towards entering the market of regenerative medicine.

A trio of tissue engineering technologies developed by researchers and clinicians from Drexel, Penn and CHOP are moving one step closer to becoming viable options for vascular surgery, skin replacement and tissue regeneration.

Scientists carrying out studies on stem cells and regenerative medicine are employing a broad range of approaches in the quest to develop novel therapeutic products, reports Genetic Engineering & Biotechnology News (GEN).

The biological scaffold that gives structure to a heart valve after its cellular material has been removed can be freeze-dried and stored for later use as a tissue-engineered replacement valve to treat a failing heart

RIT (Regenerative Injection Therapy) is a minimally invasive medical procedure that involves small injections of a natural proliferant and/or a patient's own stem cells to rebuild joints, ligaments and tendons to heal the root cause of the pain.

Philanthropic contributions are helping to speed and expand research into regenerative medicine and stem cell therapies.

Advances Made in Regenerative Medicine, Aesthetics and Orthopedics

IQPC’s Commercialization of Regenerative Medicine Conference focuses on surmounting challenges faced by the industry

Stem cell storage is like a safety deposit box for your health. With regenerative medicine, your future self will thank you.

WA Regenerative Medicine signed a milestone agreement today with University of Southern California, which aims at sharing research, and applying breakthrough medicine to help improve the lives of people in the Greater China Region.

Excess fat from liposuction procedures can be turned into adult stem cells and preserved for future treatment options.

Medical applications for adult stem cells are still in the research phase, but real-life health solutions are being formed.

Company Launches Dental Pulp Stem Cell Services to a Panel of More than 80 Leading Dentists at Robert Morgan Dental Clinic

InvestorStemCell.com is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements in the regenerative medicine sector.

Genesis Biosystems announces a business partnership with Cryo-Save, Europe's leading stem cell cryopreservation bank.

Glenn D. Prestwich, Director of the Therapeutic Biomaterials Center, Special Presidential Assistant for Faculty Entrepreneurism and Presidential Professor of Medicinal Chemistry at the University of Utah will give a presentation on GTC's conference.

Adult stem cells and regenerative medicine are the future. American CryoStem takes patients one step closer to guaranteeing future health by preserving adult stem cells for personal use.

. A new report by visiongain, a London-based business information company, predicts that world regenerative medicine revenues will reach $8.84bn in 2021. That market generated $0.82bn in 2010.

curasan AG has received FDA certification for its new granular bone regeneration material Ceracell® Dental

Biobanking 2011, taking place in London, July 2011, acts as a bridge between the worlds’ leading academia and pharma; this is the perfect forum to network with a targeted delegate audience and contribute to the successful future of drug discovery.

WA Optimum Health Care organizes series of public service events to educate on radiation.

curasan AG has received European approval for a novel synthetic bone regeneration material

curasan AG has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone® Dental which already has been authorized in the EU as Osbone®

Overcoming the current technological and regulatory barriers to the development of this exciting branch of modern medicine will be discussed by leading academics working in regenerative medicine and cell biology

WA Optimum Health Care, offering the best primary, integrative and aesthetic health care under 1 roof in a 5 star setting has opened in a beautiful garden in central Shanghai, China.

curasan AG has received the certification for the synthetic bone regeneration material Cerasorb® M ORTHO from the Canadian authorities, Health Canada

curasan AG expects to make a considerable profit instead of the two million euro loss announced for the financial year 2010

Supporting wound healing and tissue regeneration through the extraction of autologous platelet-mediator-concentrate (PMC) – high patient compatibility using autologous blood – No need for centrifuges and external laboratories

CLEVELAND, OHIO – Sergey Dzugan, MD, PhD, co-founder of Dzugan Method Restorative Medicine and world thought leader in hormonal therapy has been invited to speak at BCAARM, Bangkok, Thailand on September 2-4, 2010.

CLEVELAND, OHIO – Sergey Dzugan, MD PhD and George Rozakis, MD, founders of Dzugan Method and world thought leaders in hormonal therapy have been invited to lecture once again in Sao Paulo, Brazil at the November 17-20, 2010 A4M conference.

curasan AG, listed in the General Standard of the German Stock Exchange, was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009

The employees of curasan AG awaited the recently produced batch of Cerasorb® M with particular excitement

In Germany alone, every year about 800,000 tooth implants are placed. In the case of almost every second patient bone augmentation is necessary, because the jawbone atrophy is already too advanced.

Machine that prints body tissues coming to market thanks to Foundation investment

curasan AG, listed in the General Standard of the Deutsche Börse AG, is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States

Clinical testing of novel therapies of advances in tissue engineering and regenerative medicine will one day enable the replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

A new study was presented at the 4th Annual Congress of the German Spine Society in Munich – it demonstrated the long-term effect of Curavisc® in the treatment of chronic facet syndrome

curasan AG has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®

curasan AG, which is listed on the General Standard of the German Stock Exchange, has signed a research and development agreement with the Ben-Gurion University of the Negev (BGU), Israel

curasan AG has been received CE certification and, therefore, marketing authorization for the ATR® (Advanced Tissue Regeneration) product

curasan AG is to invest in its future growth by implementing a technological investment programme amounting to approximately 1 million euros, despite the current crisis in the financial markets

GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (to be held October 14-16, 2009 in San Diego, CA) has an important focus on Stem Cell Discovery & Development.

the Cell Therapy Group has committed financial support in 2009 to the cell therapy industry's leading non-profit organization, ISCT (the International Society for Cellular Therapy) and challenges its corporate peers to do the same.

Cellastra Inc., a San Francisco based pioneering stem cell engineering and therapeutics company, today announced the appointment of Dr. Harriet Wallberg-Henriksson, President, Karolinska Institutet, Sweden to its Scientific Advisory Board.